World Antiemetics Market Opportunities and Forecasts, 2017-2018 & 2019-2023 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “World Antiemetics Market – Opportunities and Forecasts, 2017 – 2023” report has been added to ResearchAndMarkets.com’s offering.

Antiemetics are therapeutic agents that are effective against nausea and vomiting. Nausea and vomiting are the symptoms of several medical conditions such as motion sickness, dizziness, pregnancy, emotional stress and food poisoning. These drugs are often used to treat the side effects of other medications including opioid analgesics, Chemotherapy and general anesthetics.

Global antiemetics market is expected to grow with healthy CAGR during the forecast period due to increase in number of patients suffering from cancer and increased number of surgeries. In-depth discussion of global antiemetics market includes past and current trends with future forecast up to 2020.

Profound assessment of threats and opportunities for new and existing companies running the business in this market would be beneficial to strategist in their respective decision making process. The report is informative towards geographical segmentation and identifies profitable areas.

Over the few years, antiemetics have witnessed sudden increase in sale due to increasing number of cancer patients. Nausea and vomiting are the common symptoms of chemotherapy and high risk chemotherapeutic agents include Carmustine and Cisplatin. Additional market drivers include extensive research activities to innovate universal antiemetic drug therapy, use of novel drug delivery to improve patient compliance and identification of new drug targets. However, the antiemetic drugs, which are in clinical phase requires improvement in clinical trial design for their commercialization.

Moreover, lack of suitable animal model that will mimic the human responses to antiemetic therapy also restraints the market growth. Novel drug therapies and new drug targets are the opportunities for manufacturers that would help them to increase their market share.

Global Antiemetics Market by Type

The antiemetics market is segmented by type of drugs into different categories such as 5-HT3 receptor antagonists, Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids and Others. 5-HT3 receptor antagonists, Dopamine antagonists and Cannabinoids are popular categories of antiemetics. Dronabinol is the largest selling drug from Cannabinoids, whereas Domperidone dominates the dopamine antagonists. Ondansetron, Dolasetron and Palonosetron are the top selling drugs from 5-HT3 receptor antagonists.

Global Antiemetics Market by Application

Antiemetics are used to treat the emesis arising from several medical conditions and include Chemotherapy, Motion sickness, Gastroenteritis, general anesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress and Others. Chemotherapy leads the application segment as number of patients suffering from cancer is increasing day by day.

Global Antiemetics Market by Geography

Geographically, global antiemetics market is segmented into North America, Europe, Asia-pacific and LAMEA. North America and Europe leads the global antiemetics market due to high incidence of cancer. Asia-Pacific is the fastest growing market due to increasing number of cancer population, high incidences of gastroenteritis and other diseases that lead to nausea and vomiting.

Competitive Landscape

The leading companies in global antiemetics market include GlaxoSmithCline, Merck, Sanofi-Aventis, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, Astellas Pharma, Johnson & Johnson, Baxter International and others. Antiemetics market has witnessed a strong competition due to large number of companies are trying to focus their R&D efforts to manufacture universal antiemetic therapy, which would offer improved patient compliance. Competitors are also focusing on novel drug deliveries that would show better outcomes as compared to conventional therapies.

High Level Analysis

The study identifies the potential market drivers, challenges and trends. Competitive landscape section provides explicit information of the top players ruling the global antiemetics market, their operating strategies, new launches, pipeline therapies and clinical trials. Porter’s Five Forces analysis has been used to determine the attractiveness of global antiemetics market. Market landscape for antiemetics is varied and contains numerous big and small players.

Moreover, demand for antiemetic drugs is high due to increasing number of cancer population and diseases that lead to nausea and vomiting. Hence, supplier’s power is moderate for global antiemetics market. Antiemetics are the secondary indication for many of the medical conditions and it fascinates new companies to enter the market. Industrial rivalry is intense due to exhaustive R&D activities and clinical trials to innovate the universal antiemetic therapy.

Scope of the Report

MARKET BY TYPE

– 5-HT3 receptor antagonists

– Dopamine antagonists

– NK1 receptor antagonist

– Antihistamines (H1 histamine receptor antagonists)

– Cannabinoids

– Benzodiazepines

– Anticholinergics

– Steroids

– Others

MARKET BY APPLICATION

– Chemotherapy

– Motion sickness

– Gastroenteritis

– General anesthetics

– Opioid analgesics

– Dizziness

– Pregnancy

– Food poisoning

– Emotional stress

– Others

For more information about this report visit https://www.researchandmarkets.com/r/4i3oxm

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900